Answers are grounded in this paper and cite their sources.
A case is presented of a thin diabetic male who was resistant to large doses of sc and im insulin but responded to small dose of insulin given iv. His serum contained an enzyme that degraded [125I]insulin in vitro. We postulate that his apparent insulin resistance was due to inactivation of insulin at the injection site. We propose that the sera of patients with insulin resistance be tested for [125I]insulin-degrading activity as a possible means of identifying patients with this syndrome.
No takes yet. Share an insight, caveat, or question.
Misbin et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: